Patrick Lin - 05 Apr 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Apr 2024
Net transactions value
-$1,967
Form type
4
Filing time
02 Aug 2024, 17:28:43 UTC
Previous filing
01 Feb 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1,675 +6.1% 29,225 05 Apr 2024 Direct F1
transaction PCSA Common Stock Tax liability $1,504 -539 -1.8% $2.79 28,686 05 Apr 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +2.2% 29,330 10 Jul 2024 Direct F1
transaction PCSA Common Stock Tax liability $463 -271 -0.92% $1.71 29,059 10 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +2,713 +14% $0.000000 22,201 28 Jun 2024 Common Stock 2,713 $0.000000 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2,035 +9.2% $0.000000 24,236 28 Jun 2024 Common Stock 2,035 $0.000000 Direct F3
transaction PCSA Restricted Stock Units Award $0 +339 +1.4% $0.000000 24,575 28 Jun 2024 Common Stock 339 $0.000000 Direct F4
transaction PCSA Restricted Stock Units Award $0 +339 +1.4% $0.000000 24,914 28 Jun 2024 Common Stock 339 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.